MTOR and metabolic dysfunction-associated steatotic liver disease: Dysregulation of the mTOR pathway disrupts autophagic activity, resulting in mitochondrial dysfunction and diminished glucose uptake, which collectively contribute to the progression of MASLD (93, 94).